Literature DB >> 27852663

ESRD Databases, Public Policy, and Quality of Care: Translational Medicine and Nephrology.

William M McClellan1,2, Laura C Plantinga3,2, Adam S Wilk4, Rachel E Patzer3,5.   

Abstract

Efforts to improve care of patients with ESRD and the policies that guide those activities depend on evidence-based best practices derived from clinical trials and carefully conducted observational studies. Our review describes this process in the context of the translational research model (bench to bedside to populations), with a particular emphasis on bedside care. We illustrate some of its accomplishments and describe the limitations of the data and evidence supporting policy and practice.
Copyright © 2016 by the American Society of Nephrology.

Entities:  

Keywords:  Chronic; Epidemiology and outcomes; Humans; Kidney Failure; Medical Research; Public Policy; Quality improvement; Renal Insufficiency; Translational; Translational epidemiology; guidelines; nephrology; policy; surveillance

Mesh：

Year:  2016        PMID： 27852663      PMCID： PMC5220648          DOI： 10.2215/CJN.02370316

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


  38 in total

Review 1.  Nephrology training in the 21st century: toward outcomes-based education.

Authors:  Mark G Parker
Journal:  Am J Kidney Dis       Date:  2010-04-24       Impact factor: 8.860

2.  Validation of erythropoietin use data on Medicare's End-Stage Renal Disease Medical Evidence Report.

Authors:  Michael J Fischer; Kevin T Stroupe; Denise M Hynes; Pierre Blemur; Min-Woong Sohn; Margaret M Browning; Zhiping Huo; Ann M O'Hare; James S Kaufman
Journal:  J Rehabil Res Dev       Date:  2010

3.  The health care quality improvement initiative. A new approach to quality assurance in Medicare.

Authors:  S F Jencks; G R Wilensky
Journal:  JAMA       Date:  1992-08-19       Impact factor: 56.272

4.  Introduction and summary. Proceedings from the Morbidity, Mortality and Prescription of Dialysis Symposium, Dallas, Tx, September 15 to 17, 1989.

Authors: 
Journal:  Am J Kidney Dis       Date:  1990-05       Impact factor: 8.860

Review 5.  Translating evidence into population health improvement: strategies and barriers.

Authors:  Steven H Woolf; Jason Q Purnell; Sarah M Simon; Emily B Zimmerman; Gabriela J Camberos; Amber Haley; Robert P Fields
Journal:  Annu Rev Public Health       Date:  2015-01-12       Impact factor: 21.981

6.  CROWNWeb: producing data to measure performance.

Authors:  Oniel Delva; Jamila Seaton
Journal:  Nephrol News Issues       Date:  2013-12

7.  Discrepancy between Medical Evidence Form 2728 and renal biopsy for glomerular diseases.

Authors:  J Bradley Layton; Susan L Hogan; Caroline E Jennette; Barbara Kenderes; Jenna Krisher; J Charles Jennette; William M McClellan
Journal:  Clin J Am Soc Nephrol       Date:  2010-08-05       Impact factor: 8.237

Review 8.  The hemodialysis prescription and quality-adjusted life expectancy. Renal Physicians Association Working Committee on Clinical Guidelines.

Authors:  J C Hornberger
Journal:  J Am Soc Nephrol       Date:  1993-10       Impact factor: 10.121

9.  Form CMS-2728 data versus erythropoietin claims data: implications for quality of care studies.

Authors:  Anne C Beaubrun; Eiichiro Kanda; T Christopher Bond; William M McClellan
Journal:  Ren Fail       Date:  2012-12-11       Impact factor: 2.606

10.  Dialysis facility and network factors associated with low kidney transplantation rates among United States dialysis facilities.

Authors:  R E Patzer; L Plantinga; J Krisher; S O Pastan
Journal:  Am J Transplant       Date:  2014-05-29       Impact factor: 8.086
View more
  1 in total

1.  Standardized Transplantation Referral Ratio to Assess Performance of Transplant Referral among Dialysis Facilities.

Authors:  Sudeshna Paul; Laura C Plantinga; Stephen O Pastan; Jennifer C Gander; Sumit Mohan; Rachel E Patzer
Journal:  Clin J Am Soc Nephrol       Date:  2018-01-25       Impact factor: 8.237
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.